Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Collins

Showing results (11-20 of 265) with videos related to

Pageof 27
Sort By:
Applied and Environmental Microbiology|November 7, 2003
Variation in resistance of Mycobacterium paratuberculosis to acid environments as a function of culture mediumNackmoon Sung, Michael T Collins
Reviews in Endocrine & Metabolic Disorders|August 23, 2015
The PTH-Vitamin D-FGF23 axisJenny E Blau, Michael T Collins
Inflammatory Bowel Diseases|November 25, 2005
Debate on the lack of evidence of Mycobacterium avium subsp. paratuberculosis in Crohn's diseaseSaleh A Naser, Michael T Collins
Endocrine Reviews|November 2, 2019
Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s ActivationAlison M Boyce, Michael T Collins
Lancet (London, England)|August 4, 2004
Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?Robert J Greenstein, Michael T Collins
Orphanet Journal of Rare Diseases|May 21, 2008
McCune-Albright syndromeClaudia E Dumitrescu, Michael T Collins
Antimicrobial Agents and Chemotherapy|December 12, 2007
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitroSung Jae Shin, Michael T Collins
Journal of Children'S Orthopaedics|March 25, 2009
Current approach to fibrous dysplasia of bone and McCune-Albright syndromeArabella I Leet, Michael T Collins
The New England Journal of Medicine|May 3, 2019
HypoparathyroidismRachel I Gafni, Michael T Collins
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2021
Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good ThingIris R Hartley, Michael T Collins
Pageof 27

Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
Applied and Environmental Microbiology|November 7, 2003
Variation in resistance of Mycobacterium paratuberculosis to acid environments as a function of culture mediumNackmoon Sung, Michael T Collins
Reviews in Endocrine & Metabolic Disorders|August 23, 2015
The PTH-Vitamin D-FGF23 axisJenny E Blau, Michael T Collins
Inflammatory Bowel Diseases|November 25, 2005
Debate on the lack of evidence of Mycobacterium avium subsp. paratuberculosis in Crohn's diseaseSaleh A Naser, Michael T Collins
Endocrine Reviews|November 2, 2019
Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s ActivationAlison M Boyce, Michael T Collins
Lancet (London, England)|August 4, 2004
Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?Robert J Greenstein, Michael T Collins
Orphanet Journal of Rare Diseases|May 21, 2008
McCune-Albright syndromeClaudia E Dumitrescu, Michael T Collins
Antimicrobial Agents and Chemotherapy|December 12, 2007
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitroSung Jae Shin, Michael T Collins
Journal of Children'S Orthopaedics|March 25, 2009
Current approach to fibrous dysplasia of bone and McCune-Albright syndromeArabella I Leet, Michael T Collins
The New England Journal of Medicine|May 3, 2019
HypoparathyroidismRachel I Gafni, Michael T Collins
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2021
Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good ThingIris R Hartley, Michael T Collins
Pageof 27